Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death

Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death

Bibliographic Details
Main Author:	Allan D Struthers
Format:	Article
Language:	English
Published:	SAGE Publications 2001-12-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.3317/jraas.2001.033

Similar Items

Aldosterone blockade in heart failure
by: Allan D Struthers
Published: (2004-03-01)

Aldosterone blockade in heart failure
by: Allan D Struthers
Published: (2004-03-01)

Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus
by: Justine Davies, et al.
Published: (2002-09-01)

Review: Aldosterone Inhibition Reduces the Risk of Sudden Cardiac Death in Patients with Heart Failure
by: Kishlay Anand, et al.
Published: (2006-03-01)

Aldosterone and Cortisol affect the risk of sudden cardiac death in hemodialysis patients
Published: (2012-06-01)

Lack of rapid aldosterone effects on forearm resistance vasculature in health
by: Prasad Gunaruwan, et al.
Published: (2002-06-01)

Aldosterone Blockade Over and Above ACE-Inhibitors in Patients with Coronary Artery Disease but without Heart Failure
by: Nimit C Shah, et al.
Published: (2006-03-01)

Cardiac allograft vasculopathy: How can it be predicted?
by: Rita Calé, et al.
Published: (2020-04-01)

Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen.
by: Brodsky, S, et al.
Published: (2004)

Cardiac allograft vasculopathy. A disease on the search for therapy
by: Francisco González Vílchez, et al.
Published: (2019-08-01)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
by: Tracey M Ellimuttil, et al.
Published: (2021-11-01)

Cocaine/levamisole-induced vasculopathy
by: Chevalier Michelle T., et al.
Published: (2012-01-01)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
by: Kobashigawa Jon
Published: (2000-12-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
by: Wenxia Chai, et al.
Published: (2006-12-01)

Functional Assessment of Long-Term Microvascular Cardiac Allograft Vasculopathy
by: Noemi Bora, et al.
Published: (2023-12-01)

Factors associated with cardiac allograft vasculopathy after heart transplantation
by: Wioletta Szczurek-Wasilewicz, et al.
Published: (2022-10-01)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
by: Nandini Nair
Published: (2022-08-01)

A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
by: Anais Huot, et al.
Published: (2022-03-01)

Varicella zoster virus Vasculopathy as a Rare Cause of Stroke
by: Fatma Şimşek, et al.
Published: (2023-07-01)

Cardiac allograft vasculopathy: Incidence and predictors in a single-center cohort
by: Sofia Picão, et al.
Published: (2020-04-01)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
by: Milena A. Gebska, MD, PhD, et al.
Published: (2020-02-01)

Proanthocyanidins Maintain Cardiac Ionic Homeostasis in Aldosterone-Induced Hypertension and Heart Failure
by: Natalia de las Heras, et al.
Published: (2021-09-01)

Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation
by: Martina Tetti, et al.
Published: (2022-08-01)

Vasculopathy in dermatomyositis
by: Xu Hui, et al.
Published: (2024-01-01)

Livedoid vasculopathy
by: Thiago Quadrante Freitas, et al.
Published: (2018-08-01)

Livedoid vasculopathy
by: José Roberto Provenza, et al.

ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CARDIAC ALLOGRAFT VASCULOPATHY DEVELOPMENT
by: V. V. Chestukhin, et al.
Published: (2013-03-01)

PREGNANCY-ASSOCIATED PLASMA PROTEIN A (PAPP-A) IN CARDIAC ALLOGRAFT VASCULOPATHY
by: О. P. Shevchenko, et al.
Published: (2011-06-01)

New Concepts for the Diagnosis of Polypoidal Choroidal Vasculopathy
by: Jinzhi Zhao, et al.
Published: (2023-05-01)

Preclinical cardiac disease in women and men with primary aldosteronism
by: Arleen Aune, et al.
Published: (2021-07-01)

Cardiac sarcoidosis causing sudden death
by: Suranagi Vijayalaxmi, et al.
Published: (2009-10-01)

Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
by: Moaz A. Kamel, et al.
Published: (2024-03-01)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
by: Pooja Prasad, et al.
Published: (2023-10-01)

Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
by: Fernando Bacal, et al.
Published: (2000-11-01)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
by: Ricardo Wang, et al.
Published: (2015-01-01)

Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy
by: William Durante
Published: (2022-03-01)

Evolution and diabetic vasculopathy
by: Hiroshi Yamamoto, et al.
Published: (2022-07-01)

Polypoidal Choroidal Vasculopathy
by: Mirza Metita, et al.
Published: (2018-08-01)